DENVER INVESTMENT ADVISORS LLC - ALBANY MOLECULAR RESH INC ownership

ALBANY MOLECULAR RESH INC's ticker is AMRI and the CUSIP is 012423109. A total of 143 filers reported holding ALBANY MOLECULAR RESH INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
DENVER INVESTMENT ADVISORS LLC ownership history of ALBANY MOLECULAR RESH INC
ValueSharesWeighting
Q1 2017$430,000
-28.3%
30,636
-4.2%
0.02%
-24.0%
Q4 2016$600,000
+97.4%
31,986
+132.5%
0.02%
+150.0%
Q3 2014$304,000
+166.7%
13,756
+22.0%
0.01%
+233.3%
Q4 2013$114,000
-21.4%
11,2790.0%0.00%0.0%
Q3 2013$145,00011,2790.00%
Other shareholders
ALBANY MOLECULAR RESH INC shareholders Q1 2017
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 302,400$4,243,0007.26%
Permian Investment Partners, LP 3,181,577$44,638,0006.90%
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP 1,738,764$24,395,0002.25%
AMERICAN CAPITAL MANAGEMENT INC 2,157,370$30,268,0002.14%
Walthausen & Co., LLC 831,285$11,663,0001.20%
Netols Asset Management, Inc. 371,226$5,208,0001.17%
RICE HALL JAMES & ASSOCIATES, LLC 1,234,440$17,319,0000.84%
AMI ASSET MANAGEMENT CORP 705,493$9,898,0000.74%
Evercore Wealth Management, LLC 1,040,211$14,594,0000.57%
Lombard Odier Asset Management (USA) Corp 421,100$5,908,0000.56%
View complete list of ALBANY MOLECULAR RESH INC shareholders